Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Orthofix Medical Inc.OFIX · Entity 1975 | Director | June 10, 2026 | June 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Orthofix Medical Inc.
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 102,727 |
Reported balance
After 2026-06-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-10 · Grant · Acquired 14,965 · Balance 102,727 F1: Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer. F2: Includes 73,541 previously reported deferred stock units and 814 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.
F2: Includes 73,541 previously reported deferred stock units and 814 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2026 Filed Jun 12, 2026 22:24 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 14,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-269861 · ownership.xml · nonDerivative · entry 1 Paolucci Michael E · CIK 0001599463 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,727 F1 · shares: Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer. F2 · balance_after: Includes 73,541 previously reported deferred stock units and 814 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b). Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 20:19 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 18,841 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-088997 · ownership.xml · nonDerivative · entry 1 Paolucci Michael E · CIK 0001599463 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,948 F1 · shares: Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer. F2 · balance_after: Includes 54,700 previously reported deferred stock units and 1,341 shares acquired under Orthofix's Stock Purchase Plan on 10/31/2024. Read SEC document |
| June 18, 2024 Filed Jun 20, 2024 11:06 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 15,152 | $12.87 | $195,006.24 |
DisclosureSEC source: 0000950170-24-075303 · ownership.xml · nonDerivative · entry 1 Paolucci Michael E · CIK 0001599463 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,766 F1 · shares: Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer. F2 · balance_after: Includes 54,700 deferred stock units. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 23:48 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 14,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002640 · doc4.xml · nonDerivative · entry 1 Paolucci Michael E · CIK 0001599463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,687 F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the first anniversary of the grant date, January 5, 2023. F2 · balance_after: Includes 39,246 deferred stock units. Read SEC document |
| January 05, 2023 Filed Feb 9, 2023 23:00 UTC Amendment | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 14,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-008130 · doc4a.xml · nonDerivative · entry 1 Paolucci Michael E · CIK 0001599463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,989 F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the earlier of (i) June 30, 2024 or (ii) the date that the Company holds its 2024 annual meeting of stockholders. F2 · shares: This amendment is being made to correct the vesting date and the number of Deferred Stock Units awarded to the reporting person on January 5, 2023. F3 · balance_after: Includes 39,548 deferred stock units. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 20:31 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 6,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035038 · doc4.xml · nonDerivative · entry 1 Paolucci Michael E · CIK 0001599463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,903 F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vest in full on the first anniversary of the grant date, June 6, 2022. Read SEC document |
| November 22, 2021 Filed Nov 22, 2021 23:02 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | PurchaseCommon Stock | 2,000 | $31.15 | $62,300.00 |
DisclosureSEC source: 0001209191-21-066189 · doc4.xml · nonDerivative · entry 1 Paolucci Michael E · CIK 0001599463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,141 Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 20:29 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 4,313 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-042743 · doc4.xml · nonDerivative · entry 1 Paolucci Michael E · CIK 0001599463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,814 F1 · shares: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The award vests in full on the first anniversary of the grant date, June 21, 2021. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 22:00 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 4,588 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035657 · doc4.xml · nonDerivative · entry 1 Paolucci Michael E · CIK 0001599463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,779 F1 · shares: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The award vests in full on the first anniversary of the grant date, June 8, 2020. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 22:00 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 3,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-036916 · doc4.xml · nonDerivative · entry 1 Paolucci Michael E · CIK 0001599463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,860 F1 · shares: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The award vests in full on the first anniversary of the grant date, June 11, 2019. Read SEC document |
| July 17, 2018 Filed Jul 17, 2018 23:01 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 2,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-042919 · doc4.xml · nonDerivative · entry 1 Paolucci Michael E · CIK 0001599463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,429 F1 · shares: Deferred Stock Unit award granted on July 2, 2018, subject to shareholder approval, which was obtained on July 17, 2018, and is subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These awards vest in full on July 2, 2019. Read SEC document |
| July 03, 2017 Filed Jul 10, 2017 21:55 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 3,579 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-044650 · doc4.xml · nonDerivative · entry 1 Paolucci Michael E · CIK 0001599463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,529 F1 · shares: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These awards vest in full on July 3, 2018. Vested shares of common stock will be delivered to the reporting person within 45 days after termination of service as a director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.